CGTX
COGNITION THERAPEUTICS INC
Latest Form 4:Purchase$11KbyCaggiano Anthony (Chief Medical Officer) · filed Apr 20, 2026
COGNITION THERAPEUTICS INC (CGTX) has 19 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 22, 2026.
- Industry:Biotechnology
- CEO:Lisa Ricciardi
- Employees:14
- HQ:Purchase, NY, US
- IPO:2021-10-08
Insider Buying
$32K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$97.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Caggiano AnthonyFirst filing | Chief Medical Officer | Purchase | 10,000 | $11K | Apr 20 | SEC ↗ |
Ricciardi LisaFirst filing | CEO & President | Purchase | 9,175 | $10K | Apr 20 | SEC ↗ |
Doyle John BrendanFirst filing | Chief Financial Officer | Purchase | 10,000 | $11K | Apr 20 | SEC ↗ |
Related companies
COGNITION THERAPEUTICS INC is in the Healthcare sector.